FDA 483 - Robert Clifford, M.D. - August 22, 2018

An FDA inspection of Robert Clifford, a clinical investigator in Charleston, SC, revealed that a clinical investigation was not conducted in accordance with its investigational plan. Specifically, issues were identified with subject eligibility at enrollment and the non-concurrent completion of subject diary cards. These observations indicate deficiencies in adhering to study protocols and maintaining accurate study records.